Figures & data
Figure 1. The underlying immuno-regulatory mechanisms accompanied by T cell-dependent protective response or chemokine-mediated inflammatory response.
![Figure 1. The underlying immuno-regulatory mechanisms accompanied by T cell-dependent protective response or chemokine-mediated inflammatory response.](/cms/asset/2de4af6c-7e23-4381-a2f0-dcb658867950/ilab_a_2177605_f0001_c.jpg)
Figure 2. The crosstalk between NK cells, T cells, and DCs induces the innate and adaptive response in SARS-CoV-2-infected patients with mild to moderate symptoms.
![Figure 2. The crosstalk between NK cells, T cells, and DCs induces the innate and adaptive response in SARS-CoV-2-infected patients with mild to moderate symptoms.](/cms/asset/61b80271-788a-4f8d-9031-dffdeb2ff7b9/ilab_a_2177605_f0002_c.jpg)
Figure 5. The idiosyncratic immune-modulatory effect is associated with the paracrine factors produced by MSC-mediated therapy.
![Figure 5. The idiosyncratic immune-modulatory effect is associated with the paracrine factors produced by MSC-mediated therapy.](/cms/asset/9a09858e-070c-46b6-afd2-c731a0aa9c22/ilab_a_2177605_f0005_c.jpg)
Table 1. Examples of ongoing interventional clinical trials registered at ClinicalTrials.gov employ cellular-based therapy to treat and prevent COVID-19 infection.